http://staging.inmedpharma.com/news_release/inmed-pharmaceuticals-inc-announces-non-brokered-private-placement-of-c250000/ 2018-05-18T05:09:49+00:00 http://staging.inmedpharma.com/news_release/inmed-announces-appointment-of-eric-a-adams-as-ceo-president-and-director/ 2018-05-18T05:09:49+00:00 http://staging.inmedpharma.com/news_release/inmed-announces-appointment-of-william-j-garner-m-d-to-its-board-of-directors/ 2018-05-18T05:09:49+00:00 http://staging.inmedpharma.com/news_release/inmed-updates-progress-of-its-epidermolysis-bullosa-program/ 2018-05-18T05:09:50+00:00 http://staging.inmedpharma.com/news_release/inmed-pharmaceuticals-provides-strategic-update-on-its-business-plans-announces-planned-executive-and-board-departures/ 2018-05-18T05:09:50+00:00 http://staging.inmedpharma.com/news_release/inmed-announces-update-on-biosynthesis-project/ 2018-05-18T05:09:51+00:00 http://staging.inmedpharma.com/news_release/inmed-strengthens-board-with-appointment-of-experienced-biotech-executive-adam-cutler/ 2018-05-18T05:09:51+00:00 http://staging.inmedpharma.com/news_release/inmed-provides-update-on-progress-of-its-development-program-for-epidermolysis-bullosa/ 2018-05-18T05:09:52+00:00 http://staging.inmedpharma.com/news_release/inmed-pharmaceuticals-inc-announces-non-brokered-private-placement-for-up-to-c1000000/ 2018-05-18T05:09:52+00:00 http://staging.inmedpharma.com/news_release/inmed-appoints-paul-brennan-as-president-chief-executive-officer/ 2018-05-18T05:09:53+00:00 http://staging.inmedpharma.com/news_release/inmed-commences-development-of-proprietary-drug-delivery-system/ 2018-05-18T05:09:53+00:00 http://staging.inmedpharma.com/news_release/inmed-appoints-paul-brennan-to-the-board-of-directors/ 2018-05-18T05:09:54+00:00 http://staging.inmedpharma.com/news_release/inmed-pharmaceuticals-announces-progress-in-orofacial-pain-program/ 2018-05-18T05:09:54+00:00 http://staging.inmedpharma.com/news_release/inmed-adds-chronic-obstructive-pulmonary-disease-copd-program-to-therapeutic-pipeline/ 2018-05-18T05:09:55+00:00 http://staging.inmedpharma.com/news_release/inmed-pharmaceuticals-files-provisional-patent-covering-novel-compounds-for-treating-epidermolysis-bullosa-simplex-ebs/ 2018-05-18T05:09:55+00:00 http://staging.inmedpharma.com/news_release/inmed-pharmaceuticals-files-provisional-patent-for-compositions-treating-eye-diseases/ 2018-05-18T05:09:56+00:00 http://staging.inmedpharma.com/news_release/inmed-pharmaceuticals-inc-closes-non-brokered-private-placement-for-c1232750/ 2018-05-18T05:09:56+00:00 http://staging.inmedpharma.com/news_release/inmed-engages-peter-mountford-as-strategic-advisor/ 2018-05-18T05:09:56+00:00 http://staging.inmedpharma.com/news_release/inmed-pharmaceuticals-qualifies-for-electronic-trading-in-the-u-s/ 2018-05-18T05:09:57+00:00 http://staging.inmedpharma.com/news_release/inmed-awarded-grant-for-proprietary-nanoparticle-based-delivery-system-for-glaucoma-therapy/ 2018-05-18T05:09:57+00:00 http://staging.inmedpharma.com/news_release/inmed-pharmaceuticals-inc-announces-non-brokered-private-placement-for-up-to-c1000000-2/ 2018-05-18T05:09:58+00:00 http://staging.inmedpharma.com/news_release/inmed-pharmaceuticals-strengthens-scientific-advisory-board/ 2018-05-18T05:09:58+00:00 http://staging.inmedpharma.com/news_release/inmed-receives-exemption-status-from-health-canada/ 2018-05-18T05:09:59+00:00 http://staging.inmedpharma.com/news_release/inmed-pharmaceuticals-added-to-cse-composite-index/ 2018-05-18T05:09:59+00:00 http://staging.inmedpharma.com/news_release/inmed-initiates-pre-clinical-work-on-orofacial-pain/ 2018-05-18T05:09:59+00:00 http://staging.inmedpharma.com/news_release/inmed-forms-strategic-collaboration-to-develop-novel-phytocannabinoid-therapies-for-ocular-allergies/ 2018-05-18T05:10:00+00:00 http://staging.inmedpharma.com/news_release/inmed-pharmaceuticals-appoints-dr-ado-mohammed-as-chief-medical-officer/ 2018-05-18T05:10:00+00:00 http://staging.inmedpharma.com/news_release/inmed-pharmaceuticals-to-present-live-investor-webcast-march-5-2015/ 2018-05-18T05:10:01+00:00 http://staging.inmedpharma.com/news_release/inmed-expands-board-of-directors-with-senior-life-science-and-financial-executives-appoints-tarek-s-mansour-ph-d-and-kevin-puil-to-board-of-directors/ 2018-05-18T05:10:01+00:00 http://staging.inmedpharma.com/news_release/inmed-pharmaceuticals-inc-closes-non-brokered-private-placement-for-up-to-c1050000/ 2018-05-18T05:10:02+00:00 http://staging.inmedpharma.com/news_release/inmed-pharmaceuticals-inc-announces-non-brokered-private-placement-for-up-to-c500000/ 2018-05-18T05:10:02+00:00 http://staging.inmedpharma.com/news_release/inmed-to-present-at-30th-annual-roth-capital-conference/ 2018-05-18T05:23:08+00:00 http://staging.inmedpharma.com/news_release/inmed-announces-peer-reviewed-publication-in-drug-delivery-and-translational-research/ 2018-05-18T05:23:08+00:00 http://staging.inmedpharma.com/news_release/inmed-to-present-at-canaccord-genuity-conference/ 2018-05-18T05:23:09+00:00 http://staging.inmedpharma.com/news_release/inmed-closes-over-subscribed-c9-4-million-financing/ 2018-05-18T05:23:09+00:00 http://staging.inmedpharma.com/news_release/inmed-clarifies-3rd-party-news-coverage/ 2018-05-18T05:23:10+00:00 http://staging.inmedpharma.com/news_release/inmed-announces-non-brokered-private-placement/ 2018-05-18T05:23:10+00:00 http://staging.inmedpharma.com/news_release/inmed-announces-appointment-of-creative-capital-media/ 2018-05-18T05:23:14+00:00 http://staging.inmedpharma.com/news_release/inmed-announces-agreement-to-advance-a-topical-formulation-of-inm-750/ 2018-05-18T05:23:16+00:00 http://staging.inmedpharma.com/news_release/inmed-raises-5-75-million-through-underwritten-financing-including-full-exercise-of-the-over-allotment-option/ 2018-05-18T05:23:16+00:00 http://staging.inmedpharma.com/news_release/inmed-announces-pricing-of-5004000-underwritten-financing/ 2018-05-18T05:23:16+00:00 http://staging.inmedpharma.com/news_release/inmed-pharmaceuticals-announces-marketed-offering-of-common-shares/ 2018-05-18T05:23:17+00:00 http://staging.inmedpharma.com/news_release/inmed-pharmaceuticals-shareholders-approve-new-stock-option-plan-and-articles/ 2018-05-18T05:23:18+00:00 http://staging.inmedpharma.com/news_release/inmed-pharmaceuticals-to-present-at-the-29th-annual-roth-conference/ 2018-05-18T05:23:18+00:00 http://staging.inmedpharma.com/news_release/inmed-pharmaceuticals-files-pct-patent-for-epidermolysis-bullosa-simplex/ 2018-05-18T05:23:19+00:00 http://staging.inmedpharma.com/news_release/inmed-pharmaceuticals-inc-announces-non-brokered-private-placement-of-c1000000/ 2018-05-18T05:23:21+00:00 http://staging.inmedpharma.com/news_release/inmed-launches-new-website/ 2018-05-18T05:23:21+00:00 http://staging.inmedpharma.com/news_release/inmed-pharmaceuticals-announces-appointment-of-veteran-biotech-cfo-jeff-charpentier/ 2018-05-18T05:23:22+00:00 http://staging.inmedpharma.com/news_release/inmed-to-present-at-cannabis-based-therapies-conference/ 2018-05-18T05:23:22+00:00 http://staging.inmedpharma.com/news_release/inmed-pharmaceuticals-inc-closes-non-brokered-private-placement-for-c1500000-2/ 2018-05-18T05:23:23+00:00 http://staging.inmedpharma.com/news_release/inmed-pharmaceuticals-inc-announces-non-brokered-private-placement-of-c1500000/ 2018-05-18T05:23:24+00:00 http://staging.inmedpharma.com/news_release/inmed-to-present-at-18th-annual-rodman-and-renshaw-global-investment-conference/ 2018-05-18T05:23:24+00:00 http://staging.inmedpharma.com/news_release/inmed-pharmaceuticals-inc-closes-non-brokered-private-placement-for-c304500/ 2018-05-18T05:23:25+00:00 http://staging.inmedpharma.com/news_release/inmed-to-present-at-the-8th-annual-ld-micro-invitational-conference/ 2018-05-29T15:25:00+00:00 http://staging.inmedpharma.com/news_release/inmed-pharmaceuticals-announces-the-closing-of-c14-95-million-bought-deal-financing-including-full-exercise-of-underwriters-over-allotment-option/ 2018-06-21T19:13:00+00:00 http://staging.inmedpharma.com/news_release/inmed-reports-third-quarter-fiscal-2018-financial-results-and-provides-business-update/ 2018-07-18T21:46:25+00:00 http://staging.inmedpharma.com/news_release/inmed-to-present-at-the-canaccord-genuity-38th-annual-growth-conference/ 2018-08-01T15:25:00+00:00 http://staging.inmedpharma.com/news_release/inmed-files-patent-application-for-inm-085-glaucoma-program/ 2018-08-01T17:58:52+00:00 http://staging.inmedpharma.com/news_release/inmed-appoints-dr-vikramaditya-g-yadav-to-scientific-advisory-board/ 2018-08-01T17:58:52+00:00 http://staging.inmedpharma.com/news_release/inmed-rings-the-opening-bell-at-the-toronto-stock-exchange/ 2018-08-01T17:58:53+00:00 http://staging.inmedpharma.com/news_release/inmed-announces-appointment-of-joshua-blacher-as-chief-business-officer/ 2018-08-01T17:58:53+00:00 http://staging.inmedpharma.com/news_release/inmed-pharmaceuticals-announces-graduation-to-toronto-stock-exchange/ 2018-08-01T17:58:54+00:00 http://staging.inmedpharma.com/news_release/inmed-appoints-dr-eric-hsu-as-vice-president-preclinical-research-and-development/ 2018-08-01T17:58:54+00:00 http://staging.inmedpharma.com/news_release/inmed-receives-conditional-approval-to-list-on-the-toronto-stock-exchange/ 2018-08-01T17:58:55+00:00 http://staging.inmedpharma.com/news_release/inmed-to-present-at-cannabis-based-science-medicine-conference/ 2018-08-01T17:58:55+00:00 http://staging.inmedpharma.com/news_release/inmed-announces-positive-pre-clinical-data-on-an-ocular-hydrogel-formulation-using-a-biosynthesized-cannabinoid/ 2018-08-01T17:58:56+00:00 http://staging.inmedpharma.com/news_release/inmed-updates-pain-program/ 2018-08-01T17:58:56+00:00 http://staging.inmedpharma.com/news_release/inmed-appoints-dr-mauro-maccarrone-to-its-scientific-advisory-board/ 2018-08-01T17:58:57+00:00 http://staging.inmedpharma.com/news_release/inmed-pharmaceuticals-files-provisional-patent-for-pain-program/ 2018-08-01T17:58:57+00:00 http://staging.inmedpharma.com/news_release/inmed-continues-to-make-significant-strides-on-biosynthesis-program-development/ 2018-08-01T17:58:58+00:00 http://staging.inmedpharma.com/news_release/inmed-pharmaceuticals-added-to-cse25-index/ 2018-08-01T17:58:58+00:00 http://staging.inmedpharma.com/news_release/inmed-retains-consultant-ben-paterson-for-biosynthesis-development/ 2018-08-01T17:58:59+00:00 http://staging.inmedpharma.com/news_release/inmed-files-provisional-patent-for-biosynthesis-of-cannabinoids/ 2018-08-01T17:58:59+00:00 http://staging.inmedpharma.com/news_release/inmed-announces-publication-in-european-journal-of-pain/ 2018-08-01T17:58:59+00:00 http://staging.inmedpharma.com/news_release/inmed-signs-rd-agreement-with-atera/ 2018-08-01T17:59:00+00:00 http://staging.inmedpharma.com/news_release/inmed-pharmaceuticals-files-provisional-patent-application-for-ophthalmic-drug-delivery/ 2018-08-01T17:59:01+00:00 http://staging.inmedpharma.com/news_release/inmed-receives-over-1350000-from-warrant-exercise/ 2018-08-01T17:59:01+00:00 http://staging.inmedpharma.com/news_release/inmed-pharmaceuticals-to-present-at-the-2017-bio-ceo-investor-conference/ 2018-08-01T17:59:01+00:00 http://staging.inmedpharma.com/news_release/inmed-pharmaceuticals-inc-closes-non-brokered-private-placement-for-c1500000/ 2018-08-01T17:59:02+00:00 http://staging.inmedpharma.com/news_release/inmed-pharmaceuticals-appoints-martin-bott-to-board-of-directors/ 2018-08-01T17:59:02+00:00 http://staging.inmedpharma.com/news_release/inmed-provides-2016-year-end-update/ 2018-08-01T17:59:03+00:00 http://staging.inmedpharma.com/news_release/inmed-announces-progress-on-copd-program/ 2018-08-01T17:59:03+00:00 http://staging.inmedpharma.com/news_release/inmed-pharmaceuticals-inc-appoints-senior-vice-president-clinical-and-regulatory-affairs/ 2018-08-01T17:59:04+00:00 http://staging.inmedpharma.com/news_release/inmed-appoints-andrew-hull-to-the-board-of-directors/ 2018-08-01T17:59:04+00:00 http://staging.inmedpharma.com/news_release/inmed-pharmaceuticals-to-present-at-the-h-c-wainwright-20th-annual-global-investment-conference/ 2018-08-31T15:25:00+00:00 http://staging.inmedpharma.com/news_release/inmed-pharmaceuticals-to-report-fourth-quarter-and-full-year-fiscal-2018-financial-results-and-business-update-on-september-13-2018/ 2018-09-07T15:25:00+00:00 http://staging.inmedpharma.com/news_release/inmed-files-patent-application-for-its-cannabinoid-biosynthesis-program/ 2018-09-10T15:25:00+00:00 http://staging.inmedpharma.com/news_release/inmed-pharmaceuticals-announces-nserc-grant-to-the-university-of-british-columbia-in-support-of-collaborative-rd-work/ 2018-09-11T15:25:00+00:00 http://staging.inmedpharma.com/news_release/inmed-pharmaceuticals-reports-fourth-quarter-and-full-year-fiscal-2018-financial-results-and-provides-rd-and-business-update/ 2018-09-13T15:25:00+00:00 http://staging.inmedpharma.com/news_release/inmed-pharmaceuticals-files-pct-patent-application-for-the-treatment-of-pain-with-cannabinoids/ 2018-09-25T15:25:00+00:00 http://staging.inmedpharma.com/news_release/inmed-pharmaceuticals-signs-agreement-with-the-national-research-council-of-canada-for-cannabinoid-biofermentation-process-development-and-scale-up/ 2018-10-03T11:25:00+00:00 http://staging.inmedpharma.com/news_release/inmed-pharmaceuticals-to-present-at-bio-investor-forum-on-october-17-2018/ 2018-10-10T11:25:00+00:00 http://staging.inmedpharma.com/news_release/inmed-pharmaceuticals-appoints-michael-woudenberg-as-vice-president-chemistry-manufacturing-and-controls/ 2018-11-05T12:20:00+00:00 http://staging.inmedpharma.com/news_release/inmed-pharmaceuticals-to-report-first-quarter-fiscal-2019-financial-results-and-business-update-on-november-12-2018/ 2018-11-05T12:25:00+00:00 http://staging.inmedpharma.com/news_release/inmed-pharmaceuticals-reports-first-quarter-fiscal-2019-financial-results-and-provides-rd-and-business-update/ 2018-11-12T12:25:00+00:00 http://staging.inmedpharma.com/news_release/inmed-pharmaceuticals-receives-funding-from-the-government-of-canada-to-support-development-of-novel-cannabinoid-biosynthesis-program/ 2018-12-04T12:25:00+00:00 http://staging.inmedpharma.com/news_release/inmed-pharmaceuticals-to-present-at-biotech-showcase-2019-on-january-9-2019/ 2019-01-03T15:25:00+00:00 http://staging.inmedpharma.com/news_release/inmed-pharmaceuticals-announces-the-appointment-of-dr-sazzad-hossain-phd-msc-as-a-member-of-the-scientific-advisory-board-and-his-retirement-as-chief-scientific-officer/ 2019-01-11T12:25:00+00:00 http://staging.inmedpharma.com/news_release/inmed-pharmaceuticals-to-report-second-quarter-fiscal-2019-financial-results-and-business-update-on-february-12-2019/ 2019-02-05T12:25:00+00:00 http://staging.inmedpharma.com/news_release/inmed-pharmaceuticals-reports-second-quarter-fiscal-2019-financial-results-and-provides-rd-and-business-update/ 2019-02-12T12:25:00+00:00 http://staging.inmedpharma.com/news_release/inmed-pharmaceuticals-appoints-dr-steven-m-dinh-to-scientific-advisory-board/ 2019-03-06T12:25:00+00:00 http://staging.inmedpharma.com/news_release/inmed-pharmaceuticals-to-present-at-the-31st-annual-roth-conference-on-march-19-2019/ 2019-03-12T11:25:00+00:00 http://staging.inmedpharma.com/news_release/inmed-pharmaceuticals-announces-transition-to-a-single-cannabinoid-investigational-drug-candidate-inm-755-for-its-epidermolysis-bullosa-program/ 2019-03-13T11:25:00+00:00 http://staging.inmedpharma.com/news_release/inmed-continues-to-strengthen-ip-portfolio-for-its-biosynthesis-platform-technology/ 2019-03-18T11:25:00+00:00 http://staging.inmedpharma.com/news_release/inmed-pharmaceuticals-to-report-third-quarter-fiscal-2019-financial-results-and-business-update-on-may-15-2019/ 2019-05-08T11:25:00+00:00 http://staging.inmedpharma.com/news_release/inmed-pharmaceuticals-reports-third-quarter-fiscal-2019-financial-results-and-provides-rd-and-business-update/ 2019-05-15T11:25:00+00:00 http://staging.inmedpharma.com/news_release/inmed-pharmaceuticals-appoints-catherine-sazdanoff-to-board-of-directors/ 2019-07-02T11:25:00+00:00 http://staging.inmedpharma.com/news_release/inmed-pharmaceuticals-appoints-bruce-s-colwill-cpa-ca-as-chief-financial-officer-and-announces-other-leadership-changes/ 2019-08-02T11:25:00+00:00 http://staging.inmedpharma.com/news_release/inmed-pharmaceuticals-to-attend-the-2nd-annual-international-cannabinoid-derived-pharmaceuticals-summit/ 2019-08-29T11:25:00+00:00 http://staging.inmedpharma.com/news_release/inmed-pharmaceuticals-to-present-at-the-h-c-wainwright-21st-annual-global-investment-conference/ 2019-09-03T11:25:00+00:00 http://staging.inmedpharma.com/news_release/inmed-pharmaceuticals-to-report-fourth-quarter-and-full-year-fiscal-2019-financial-results-and-business-update-on-september-19-2019/ 2019-09-13T00:39:03+00:00 http://staging.inmedpharma.com/news_release/inmed-pharmaceuticals-reports-fourth-quarter-and-full-year-fiscal-2019-financial-results-and-provides-rd-and-business-update/ 2019-09-19T11:30:00+00:00 http://staging.inmedpharma.com/news_release/inmed-pharmaceuticals-to-present-at-the-regulatory-affairs-professionals-societys-annual-conference/ 2019-09-23T15:00:00+00:00 http://staging.inmedpharma.com/news_release/inmed-pharmaceuticals-to-present-at-the-bio-investor-forum/ 2019-10-18T16:25:00+00:00 http://staging.inmedpharma.com/news_release/inmed-pharmaceuticals-to-report-first-quarter-fiscal-2020-financial-results-and-business-update-on-november-8-2019/ 2019-11-04T12:30:00+00:00 http://staging.inmedpharma.com/news_release/inmed-submits-clinical-trial-application-to-evaluate-inm-755-in-phase-1-trial/ 2019-11-05T12:30:00+00:00 http://staging.inmedpharma.com/news_release/inmed-pharmaceuticals-reports-first-quarter-fiscal-2020-financial-results-and-provides-rd-and-business-update/ 2019-11-08T12:30:00+00:00 http://staging.inmedpharma.com/news_release/inmed-pharmaceuticals-to-present-at-the-cowen-conference/ 2019-11-11T13:30:00+00:00 http://staging.inmedpharma.com/news_release/inmed-receives-clinical-trial-application-approval-for-inm-755-a-rare-cannabinoid-formulation-under-development-for-the-treatment-of-epidermolysis-bullosa/ 2019-12-09T12:30:00+00:00 http://staging.inmedpharma.com/news_release/inmed-pharmaceuticals-to-present-at-the-biotech-showcase-conference/ 2020-01-08T12:30:00+00:00 http://staging.inmedpharma.com/news_release/inmed-announces-election-of-directors/ 2020-01-10T22:56:00+00:00 http://staging.inmedpharma.com/news_release/inmed-pharmaceuticals-to-attend-and-exhibit-at-eb2020-world-congress/ 2020-01-16T12:30:00+00:00 http://staging.inmedpharma.com/news_release/inmed-first-to-advance-cannabinol-cbn-into-therapeutic-clinical-trials/ 2020-01-20T12:30:00+00:00 http://staging.inmedpharma.com/news_release/inmed-expands-on-announcement-of-cannabinol-cbn-therapeutic-leadership-with-new-website-content-and-ceo-interview/ 2020-01-21T12:30:00+00:00 http://staging.inmedpharma.com/news_release/inmed-pharmaceuticals-to-report-second-quarter-fiscal-2020-financial-results-and-business-update-on-february-14-2020/ 2020-02-07T12:30:00+00:00 http://staging.inmedpharma.com/news_release/inmed-pharmaceuticals-reports-second-quarter-fiscal-2020-financial-results-and-provides-rd-and-business-update/ 2020-02-14T12:30:00+00:00 http://staging.inmedpharma.com/news_release/inmed-pharmaceuticals-announces-completed-enrollment-in-phase-1-clinical-trial-of-inm-755-cbn-cream-in-healthy-subjects/ 2020-03-10T17:24:00+00:00 http://staging.inmedpharma.com/news_release/inmed-provides-update-on-operations-in-response-to-the-covid-19-global-outbreak/ 2020-03-20T11:30:00+00:00 http://staging.inmedpharma.com/news_release/inmed-submits-clinical-trial-application-to-evaluate-inm-755-in-second-phase-1-trial/ 2020-03-24T11:30:00+00:00 http://staging.inmedpharma.com/news_release/inmed-announces-completion-of-initial-phase-1-clinical-trial-of-inm-755-cbn-cream-in-healthy-subjects/ 2020-04-01T11:30:00+00:00 http://staging.inmedpharma.com/news_release/inmed-receives-cta-approval-for-second-phase-1-clinical-trial-with-inm-755/ 2020-04-30T11:30:00+00:00 http://staging.inmedpharma.com/news_release/inmed-and-almac-group-developing-improved-cannabinoid-production-methods/ 2020-05-05T11:30:00+00:00 http://staging.inmedpharma.com/news_release/inmed-to-present-at-canaccord-genuitys-4th-annual-cannabis-conference/ 2020-05-07T11:30:00+00:00 http://staging.inmedpharma.com/news_release/inmed-pharmaceuticals-to-report-third-quarter-fiscal-2020-financial-results-and-business-update-on-may-14-2020/ 2020-05-08T11:30:00+00:00 http://staging.inmedpharma.com/news_release/notice-of-telephone-scam-impersonating-inmed/ 2020-05-08T20:39:03+00:00 http://staging.inmedpharma.com/news_release/inmed-files-pct-patent-application-for-neuroprotection-in-glaucoma/ 2020-05-12T11:30:00+00:00 http://staging.inmedpharma.com/news_release/inmed-pharmaceuticals-continues-to-strengthen-biosynthesis-patent-family/ 2020-05-19T11:30:00+00:00 http://staging.inmedpharma.com/news_release/inmed-releases-cbn-preclinical-results-in-glaucoma/ 2020-05-27T11:30:00+00:00 http://staging.inmedpharma.com/news_release/inmed-announces-filing-of-registration-statement-in-connection-with-united-states-offering-application-to-seek-nasdaq-listing-and-planned-share-consolidation/ 2020-06-19T22:20:00+00:00 http://staging.inmedpharma.com/news_release/inmed-introduces-integrasyn-an-integrated-cannabinoid-manufacturing-system/ 2020-06-24T11:30:00+00:00 http://staging.inmedpharma.com/news_release/inmed-announces-completion-of-share-consolidation/ 2020-06-30T22:18:00+00:00 http://staging.inmedpharma.com/news_release/inmed-announces-dosing-initiation-in-2nd-phase-1-trial-with-inm-755/ 2020-07-07T11:30:00+00:00 http://staging.inmedpharma.com/news_release/inmed-pharmaceuticals-to-report-full-year-fiscal-2020-financial-results-and-business-update-on-september-8-2020/ 2020-09-02T11:30:00+00:00 http://staging.inmedpharma.com/news_release/inmed-pharmaceuticals-reports-full-year-fiscal-2020-financial-results-and-provides-business-update/ 2020-09-08T11:30:00+00:00 http://staging.inmedpharma.com/news_release/inmed-pharmaceuticals-announces-additional-integrasyn-patent-filing/ 2020-09-25T01:49:07+00:00 http://staging.inmedpharma.com/news_release/inmed-announces-completion-of-subject-treatments-in-second-phase-1-clinical-trial-of-inm-755-cbn-cream-in-healthy-subjects/ 2020-09-25T01:49:07+00:00 http://staging.inmedpharma.com/news_release/inmed-pharmaceuticals-to-report-first-quarter-fiscal-2021-financial-results-and-business-update-on-november-6-2020/ 2020-11-04T12:30:00+00:00 http://staging.inmedpharma.com/news_release/inmed-reschedules-reporting-of-first-quarter-financial-results-and-business-update-to-november-13-2020/ 2020-11-05T23:21:00+00:00 http://staging.inmedpharma.com/news_release/inmed-announces-pricing-of-us8m-public-offering-and-listing-on-the-nasdaq-capital-market-under-the-symbol-inm/ 2020-11-12T14:10:00+00:00 http://staging.inmedpharma.com/news_release/inmed-pharmaceuticals-reports-first-quarter-fiscal-2021-ifrs-financial-results/ 2020-11-13T12:30:00+00:00 http://staging.inmedpharma.com/news_release/inmed-pharmaceuticals-announces-the-closing-of-us8-million-public-offering/ 2020-11-16T16:42:00+00:00 http://staging.inmedpharma.com/news_release/inmed-pharmaceuticals-and-baymedica-announce-collaboration-for-manufacturing-and-testing-of-novel-cannabinoid-therapeutics/ 2020-11-18T12:30:00+00:00 http://staging.inmedpharma.com/news_release/inmed-announces-election-of-directors-2/ 2020-11-25T01:00:00+00:00 http://staging.inmedpharma.com/news_release/inmed-announces-results-of-initial-phase-1-clinical-trial-of-inm-755-cbn-cream-in-healthy-subjects/ 2020-11-25T12:30:00+00:00 http://staging.inmedpharma.com/news_release/inmed-licenses-midrops-delivery-technology-from-eyecro-for-the-delivery-of-therapeutic-cannabinoids/ 2020-12-03T12:30:00+00:00 http://staging.inmedpharma.com/news_release/inmed-to-participate-at-virtual-conferences-in-january-2021/ 2021-01-05T23:49:05+00:00 http://staging.inmedpharma.com/news_release/inmed-announces-results-of-second-phase-1-clinical-trial-of-inm-755-cbn-cream-in-healthy-subjects/ 2021-01-08T12:30:00+00:00 http://staging.inmedpharma.com/news_release/inmed-pharmaceuticals-to-participate-in-2021-cannabinoid-derived-pharmaceuticals-industry-review-summit-europe/ 2021-01-19T19:00:00+00:00 http://staging.inmedpharma.com/news_release/inmed-announces-us4-5-million-private-placement/ 2021-02-05T14:34:00+00:00 http://staging.inmedpharma.com/news_release/inmed-pharmaceuticals-to-report-second-quarter-fiscal-2021-financial-results/ 2021-02-06T02:00:00+00:00 http://staging.inmedpharma.com/news_release/inmed-pharmaceuticals-reports-second-quarter-fiscal-2021-financial-results/ 2021-02-11T12:30:00+00:00 http://staging.inmedpharma.com/news_release/inmed-announces-closing-of-us4-5-million-private-placement/ 2021-02-16T12:30:00+00:00 http://staging.inmedpharma.com/news_release/inmed-to-present-at-virtual-conferences-in-march-2021/ 2021-03-03T23:00:00+00:00 http://staging.inmedpharma.com/news_release/inmed-pharmaceuticals-achieves-2g-l-cannabinoid-yield-with-integrasyn/ 2021-04-26T11:30:00+00:00 http://staging.inmedpharma.com/news_release/inmed-pharmaceuticals-announces-voluntary-delisting-from-tsx/ 2021-04-27T15:19:05+00:00 http://staging.inmedpharma.com/news_release/inmed-pharmaceuticals-submits-clinical-trial-applications-to-evaluate-inm-755-cannabinol-cream-in-a-phase-2-trial-for-epidermolysis-bullosa/ 2021-04-28T11:30:00+00:00 http://staging.inmedpharma.com/news_release/inmed-reports-second-quarter-fiscal-2023-financial-results-and-provides-business-update/ 2023-02-24T19:50:29+00:00 http://staging.inmedpharma.com/news_release/inmed-submits-form-12b-25/ 2023-02-24T19:50:54+00:00 http://staging.inmedpharma.com/news_release/inmed-provides-business-update-and-milestones-for-2023/ 2023-02-24T20:46:08+00:00 http://staging.inmedpharma.com/news_release/inmed-announces-results-of-2022-annual-general-meeting/ 2023-02-24T20:48:10+00:00 http://staging.inmedpharma.com/news_release/inmed-announces-appointment-of-interim-chief-financial-officer-and-change-of-auditor/ 2023-02-24T20:49:52+00:00 http://staging.inmedpharma.com/news_release/inmed-pharmaceuticals-announces-closing-of-6-million-private-placement-priced-at-a-premium-to-market/ 2023-02-24T20:51:59+00:00 http://staging.inmedpharma.com/news_release/inmed-pharmaceuticals-announces-6-million-private-placement-priced-at-a-premium-to-market/ 2023-02-24T20:54:18+00:00 http://staging.inmedpharma.com/news_release/inmed-provides-update-on-management-changes/ 2023-02-24T20:55:44+00:00 http://staging.inmedpharma.com/news_release/inmed-pharmaceuticals-advances-neurodegenerative-disease-program-with-natural-sciences-and-engineering-research-council-of-canada-nserc-alliance-grant-funding/ 2023-02-24T20:57:22+00:00 http://staging.inmedpharma.com/news_release/inmed-pharmaceuticals-reports-first-quarter-fiscal-2023-financial-results-and-provides-business-update/ 2023-02-24T20:59:19+00:00 http://staging.inmedpharma.com/news_release/registration-now-open-for-tribe-publics-webinar-event-exploring-the-neuroprotective-qualities-of-rare-cannabinoids-featuring-inmeds-management-team-on-november-17-2022/ 2023-02-24T21:55:42+00:00 http://staging.inmedpharma.com/wp-content/uploads/2022/11/InMed-Tribe-Webinar-20221117.jpg http://staging.inmedpharma.com/news_release/inmed-pharmaceuticals-supports-epidermolysis-bullosa-awareness-week/ 2023-02-24T21:57:53+00:00 http://staging.inmedpharma.com/news_release/inmed-pharmaceuticals-reports-full-year-fiscal-2022-financial-results-and-provides-business-update/ 2023-02-24T21:59:31+00:00 http://staging.inmedpharma.com/news_release/inmed-pharmaceuticals-announces-closing-of-6-million-private-placement-priced-at-a-premium-to-market-2/ 2023-02-24T22:02:18+00:00 http://staging.inmedpharma.com/news_release/inmed-pharmaceuticals-announces-6-million-private-placement-priced-at-a-premium-to-market-2/ 2023-02-24T22:04:00+00:00 http://staging.inmedpharma.com/news_release/inmed-pharmaceuticals-provides-update-on-its-core-research-and-development-programs-and-baymedica-business/ 2023-02-24T22:05:06+00:00 http://staging.inmedpharma.com/news_release/inmed-announces-share-consolidation-to-meet-nasdaq-listing-criteria/ 2023-02-24T22:06:12+00:00 http://staging.inmedpharma.com/news_release/inmed-announces-changes-to-its-board-of-directors/ 2023-02-24T22:07:29+00:00 http://staging.inmedpharma.com/news_release/inmed-announces-update-on-phase-2-clinical-trial-investigating-inm-755-cannabinol-cream-for-epidermolysis-bullosa/ 2023-02-24T22:09:01+00:00 http://staging.inmedpharma.com/news_release/inmed-announces-appointment-of-chief-operating-officer/ 2023-02-24T22:10:18+00:00 http://staging.inmedpharma.com/news_release/inmed-pharmaceuticals-receives-nasdaq-notification-regarding-minimum-bid-price-compliance/ 2023-02-24T22:14:36+00:00 http://staging.inmedpharma.com/news_release/inmed-announces-publication-of-peer-reviewed-study-highlighting-potential-role-of-rare-cannabinoids-thcv-cbc-and-others-on-skin-conditions/ 2023-02-24T22:16:01+00:00 http://staging.inmedpharma.com/news_release/inmed-launches-thcv-expanding-its-portfolio-of-rare-cannabinoids-for-the-health-and-wellness-sector/ 2023-02-24T22:18:06+00:00 http://staging.inmedpharma.com/news_release/inmed-pharmaceuticals-announces-closing-of-5-million-registered-direct-and-private-placement-offerings-priced-at-the-market-under-nasdaq-rules/ 2023-02-24T22:19:23+00:00 http://staging.inmedpharma.com/news_release/inmed-pharmaceuticals-announces-5-million-registered-direct-and-private-placement-offerings-priced-at-the-market-under-nasdaq-rules/ 2023-02-24T22:20:41+00:00 http://staging.inmedpharma.com/news_release/inmed-pharmaceuticals-reports-third-quarter-fiscal-2022-financial-results-and-provides-business-update/ 2023-02-24T22:22:08+00:00 http://staging.inmedpharma.com/news_release/inmed-to-supply-rare-cannabinoids-to-radicle-sciences-radicle-energy-study-to-assess-the-health-effects-of-thcv/ 2023-02-24T22:23:34+00:00 http://staging.inmedpharma.com/news_release/inmed-expands-patent-portfolio-with-novel-cannabinoid-analogs-and-advances-collaboration-agreement-with-leading-cannabinoid-research-expert/ 2023-02-25T01:58:04+00:00 http://staging.inmedpharma.com/news_release/inmed-expands-patent-portfolio-with-novel-cannabinoid-analogs-and-advances-collaboration-agreement-with-leading-cannabinoid-research-expert-2/ 2023-02-25T01:59:09+00:00 http://staging.inmedpharma.com/news_release/inmed-commercializes-cannabidivarin-cbdv-expanding-its-rare-cannabinoid-portfolio-for-the-health-and-wellness-sector/ 2023-02-25T02:00:21+00:00 http://staging.inmedpharma.com/news_release/inmed-to-participate-in-upcoming-investor-conferences-in-april-and-may-2022/ 2023-02-25T02:01:43+00:00 http://staging.inmedpharma.com/news_release/inmed-announces-management-changes/ 2023-02-25T02:03:18+00:00 http://staging.inmedpharma.com/news_release/inmed-to-present-at-the-34th-annual-roth-conference/ 2023-02-25T02:07:46+00:00 http://staging.inmedpharma.com/news_release/inmed-pharmaceuticals-strengthens-its-commercial-leadership-team-with-the-appointment-of-vice-president-of-sales-and-marketing-for-baymedica/ 2023-02-25T02:08:59+00:00 http://staging.inmedpharma.com/news_release/inmed-pharmaceuticals-reports-second-quarter-fiscal-2022-financial-results-and-provides-business-update/ 2023-02-25T02:14:14+00:00 http://staging.inmedpharma.com/news_release/inmed-pharmaceuticals-to-report-second-quarter-fiscal-2022-financial-results-and-business-update-on-february-15-2022/ 2023-02-25T02:15:23+00:00 http://staging.inmedpharma.com/news_release/inmed-launches-cannabicitran-cbt-expanding-its-rare-cannabinoid-portfolio-for-the-health-and-wellness-sector/ 2023-02-25T02:16:51+00:00 http://staging.inmedpharma.com/news_release/inmed-issues-annual-letter-to-shareholders-highlighting-key-accomplishments-from-2021-and-providing-2022-outlook/ 2023-02-25T02:18:33+00:00 http://staging.inmedpharma.com/news_release/registration-now-open-for-tribe-publics-webinar-event-addressing-the-increasing-demand-for-rare-cannabinoids-featuring-inmeds-management-team-on-january-6-2022/ 2023-02-25T02:20:00+00:00 http://staging.inmedpharma.com/news_release/inmed-pharmaceuticals-announces-publication-of-peer-reviewed-article-on-the-use-of-cbn-as-a-potential-treatment-for-glaucoma/ 2023-02-25T02:21:16+00:00 http://staging.inmedpharma.com/news_release/inmed-announces-results-of-2021-annual-general-meeting/ 2023-02-25T02:22:31+00:00 http://staging.inmedpharma.com/news_release/inmed-pharmaceuticals-to-participate-in-cowens-4th-annual-cannabis-conference/ 2023-02-25T02:23:44+00:00 http://staging.inmedpharma.com/news_release/inmed-pharmaceuticals-reports-first-quarter-fiscal-2022-financial-results-and-provides-business-update/ 2023-02-25T02:25:05+00:00 http://staging.inmedpharma.com/news_release/inmed-pharmaceuticals-files-pct-patent-application-for-treating-neurodegenerative-disease-using-a-rare-cannabinoid/ 2023-02-25T02:26:26+00:00 http://staging.inmedpharma.com/news_release/inmed-pharmaceuticals-completes-acquisition-of-baymedica-creating-a-market-leader-in-the-manufacturing-of-rare-cannabinoids/ 2023-02-25T02:27:51+00:00 http://staging.inmedpharma.com/news_release/inmed-pharmaceuticals-announces-commencement-of-phase-2-clinical-trial-investigating-cannabinol-cbn-a-rare-cannabinoid-in-the-treatment-of-epidermolysis-bullosa/ 2023-02-25T02:29:18+00:00 http://staging.inmedpharma.com/news_release/inmed-pharmaceuticals-to-report-full-year-fiscal-2021-financial-results-and-business-update-on-september-24-2021/ 2023-02-25T02:32:30+00:00 http://staging.inmedpharma.com/news_release/inmed-pharmaceuticals-and-baymedica-participating-in-tribe-publics-webinar-accelerating-the-commercialization-of-rare-cannabinoids/ 2023-02-25T02:33:59+00:00 http://staging.inmedpharma.com/news_release/inmed-pharmaceuticals-signs-definitive-agreement-to-acquire-baymedica-a-leading-commercial-manufacturer-of-rare-cannabinoids/ 2023-02-25T02:36:53+00:00 http://staging.inmedpharma.com/news_release/inmed-pharmaceuticals-to-present-at-the-h-c-wainwright-23rd-annual-global-investment-conference/ 2023-02-25T02:49:17+00:00 http://staging.inmedpharma.com/news_release/inmed-pharmaceuticals-to-webcast-live-at-virtualinvestorconferences-com-september-8th/ 2023-02-25T02:50:59+00:00 http://staging.inmedpharma.com/news_release/inmed-pharmaceuticals-to-present-at-the-h-c-wainwright-ophthalmology-virtual-conference/ 2023-02-25T02:52:18+00:00 http://staging.inmedpharma.com/news_release/inmed-pharmaceuticals-announces-closing-of-us12-million-private-placement-priced-at-the-market-under-nasdaq-rules/ 2023-02-25T02:53:44+00:00 http://staging.inmedpharma.com/news_release/inmed-pharmaceuticals-announces-12-million-private-placement-priced-at-the-market-under-nasdaq-rules/ 2023-02-25T02:55:19+00:00 http://staging.inmedpharma.com/news_release/inmed-pharmaceuticals-signs-non-binding-letter-of-intent-to-acquire-baymedica-a-commercial-manufacturer-of-rare-cannabinoids/ 2023-02-25T02:57:06+00:00 http://staging.inmedpharma.com/news_release/inmed-pharmaceuticals-increases-cannabinoid-yield-to-5-g-l-with-integrasyn-in-advance-of-commercial-scale-production/ 2023-02-25T02:58:36+00:00 http://staging.inmedpharma.com/news_release/inmed-pharmaceuticals-to-present-at-the-2021-bio-digital-conference/ 2023-02-25T03:00:02+00:00 http://staging.inmedpharma.com/news_release/inmed-pharmaceuticals-reports-third-quarter-fiscal-2021-financial-results/ 2023-02-25T03:01:26+00:00 http://staging.inmedpharma.com/news_release/inmed-pharmaceuticals-to-report-third-quarter-fiscal-2021-financial-results/ 2023-02-25T03:02:57+00:00 http://staging.inmedpharma.com/news_release/inmed-to-present-at-canaccord-genuitys-5th-annual-global-cannabis-conference-on-may-11th-2021/ 2023-02-25T03:04:08+00:00 http://staging.inmedpharma.com/news_release/inmed-pharmaceuticals-reports-full-year-fiscal-2021-financial-results-and-provides-business-update/ 2023-02-26T21:31:33+00:00 http://staging.inmedpharma.com/news_release/inmed-expands-pipeline-with-initiation-of-program-targeting-epidermolysis-bullosa-simplex-ebs/ 2023-03-01T23:38:48+00:00 http://staging.inmedpharma.com/news_release/inmed-announces-positive-in-vitro-study-results-of-inm-750-targeting-epidermolysis-bullosa-simplex-ebs/ 2023-03-01T23:39:45+00:00 http://staging.inmedpharma.com/news_release/inmed-to-participate-in-upcoming-investor-events-20/ 2023-03-07T08:00:00+00:00 http://staging.inmedpharma.com/news_release/inmed-announces-publication-of-peer-reviewed-study-showing-the-anti-inflammatory-potential-of-rare-cannabinoids-in-skin-conditions-18/ 2023-03-13T18:30:00+00:00 http://staging.inmedpharma.com/news_release/inmed-announces-conclusion-of-patient-enrollment-in-phase-2-clinical-trial-investigating-inm-755-cannabinol-cream-for-epidermolysis-bullosa-44/ 2023-03-28T18:30:00+00:00 http://staging.inmedpharma.com/news_release/inmed-pharmaceuticals-reports-third-quarter-fiscal-2023-financial-results-and-provides-business-update-19/ 2023-05-15T23:33:00+00:00 http://staging.inmedpharma.com/news_release/inmed-to-participate-in-fireside-chat-with-water-tower-research-on-may-23-2023-at-1pm-et-19/ 2023-05-19T04:00:00+00:00 http://staging.inmedpharma.com/news_release/inmed-to-participate-in-upcoming-virtual-investor-events-18/ 2023-05-25T05:51:00+00:00 http://staging.inmedpharma.com/news_release/inmeds-neurodegenerative-disease-study-presented-at-canadian-neuroscience-meeting/ 2023-06-01T11:30:00+00:00 http://staging.inmedpharma.com/news_release/inmed-pharmaceuticals-inc-announces-results-from-a-phase-2-clinical-trial-in-epidermolysis-bullosa/ 2023-06-22T11:30:00+00:00 http://staging.inmedpharma.com/news_release/inmed-provides-update-on-baymedica-rare-cannabinoid-business/ 2023-07-20T11:30:00+00:00 http://staging.inmedpharma.com/news_release/inmed-to-participate-in-fireside-chat-with-water-tower-research-on-july-25-2023-at-2pm-et/ 2023-07-21T11:30:00+00:00 http://staging.inmedpharma.com/news_release/inmed-to-present-at-h-c-wainwright-25th-annual-global-investment-conference/ 2023-09-07T12:30:00+00:00 http://staging.inmedpharma.com/news_release/inmed-pharmaceuticals-reports-third-quarter-fiscal-2020-financial-results-and-provides-rd-and-business-update-2/ 2023-09-15T02:06:25+00:00 http://staging.inmedpharma.com/wp-content/uploads/2020/05/Table1.jpg http://staging.inmedpharma.com/wp-content/uploads/2020/05/Table2.jpg http://staging.inmedpharma.com/wp-content/uploads/2020/05/Table3.jpg http://staging.inmedpharma.com/news_release/inmed-pharmaceuticals-reports-third-quarter-fiscal-2020-financial-results-and-provides-rd-and-business-update/ 2023-09-15T02:09:14+00:00 http://staging.inmedpharma.com/wp-content/uploads/2020/05/Table1.jpg http://staging.inmedpharma.com/wp-content/uploads/2020/05/Table2.jpg http://staging.inmedpharma.com/wp-content/uploads/2020/05/Table3.jpg http://staging.inmedpharma.com/news_release/inmed-pharmaceuticals-receives-nasdaq-notification-regarding-minimum-bid-price-compliance-2/ 2023-09-22T22:15:00+00:00 http://staging.inmedpharma.com/news_release/inmed-pharmaceuticals-reports-full-year-fiscal-2023-financial-results-and-provides-business-update/ 2023-09-29T17:21:00+00:00 http://staging.inmedpharma.com/news_release/inmed-pharmaceuticals-inc-s-inm-901-demonstrates-unique-pharmacological-effects-in-alzheimers-disease-in-preclinical-proof-of-concept-studies/ 2023-10-24T11:30:00+00:00 http://staging.inmedpharma.com/news_release/inmed-pharmaceuticals-announces-5-2-million-private-placement-and-preferred-investment-option-exercise-priced-at-the-market-under-nasdaq-rules/ 2023-10-24T20:38:00+00:00 http://staging.inmedpharma.com/news_release/inmed-pharmaceuticals-announces-the-closing-of-5-2-million-private-placement-and-preferred-investment-option-exercise-priced-at-the-market-under-nasdaq-rules/ 2023-10-26T23:15:00+00:00 http://staging.inmedpharma.com/news_release/inmed-announces-presentation-of-inm-755-phase-2-clinical-study-results-at-12th-world-congress-on-itch-wci-2023/ 2023-11-02T12:00:00+00:00 http://staging.inmedpharma.com/news_release/inmed-reports-first-quarter-fiscal-2024-financial-results-and-provides-business-update-2/ 2023-11-14T14:04:00+00:00 http://staging.inmedpharma.com/news_release/inmed-expands-its-pharmaceutical-pipeline-with-inm-089-targeting-the-treatment-of-age-related-macular-degeneration/ 2023-11-29T13:00:00+00:00 http://staging.inmedpharma.com/news_release/inmed-announces-results-of-2023-annual-general-meeting/ 2023-12-19T23:03:00+00:00 http://staging.inmedpharma.com/news_release/inmed-pharmaceuticals-provides-business-update-and-milestones-for-2024/ 2024-01-16T13:00:00+00:00 http://staging.inmedpharma.com/news_release/inmed-to-discuss-its-pharmaceutical-pipeline-and-2024-strategic-priorities-in-fireside-chat-with-water-tower-research-on-january-25-2024-at-1pm-et/ 2024-01-18T23:52:30+00:00 http://staging.inmedpharma.com/news_release/inmed-pharmaceuticals-strengthens-executive-leadership-team-with-appointment-of-ms-netta-jagpal-as-chief-financial-officer/ 2024-02-09T13:00:00+00:00 http://staging.inmedpharma.com/news_release/inmed-reports-second-fiscal-quarter-2024-financial-results-and-provides-business-update/ 2024-02-13T22:41:00+00:00 http://staging.inmedpharma.com/news_release/inmed-granted-180-day-extension-to-achieve-nasdaq-minimum-bid-compliance/ 2024-03-20T11:30:00+00:00 http://staging.inmedpharma.com/news_release/inmeds-inm-901-demonstrates-favorable-pharmacological-and-behavioral-effects-in-in-vivo-preclinical-alzheimers-disease-studies/ 2024-04-04T11:00:00+00:00 http://staging.inmedpharma.com/news_release/inmed-provides-update-on-inm-089-in-the-treatment-of-dry-age-related-macular-degeneration/ 2024-04-16T11:00:00+00:00 http://staging.inmedpharma.com/news_release/inmed-appoints-dr-david-g-morgan-phd-a-leading-alzheimers-expert-to-the-companys-scientific-advisory-board/ 2024-04-18T11:00:00+00:00 http://staging.inmedpharma.com/news_release/inmed-pharmaceuticals-reports-third-quarter-fiscal-2024-financial-results-and-provides-business-update/ 2024-05-14T11:30:00+00:00 http://staging.inmedpharma.com/news_release/inmed-to-present-at-the-emerging-growth-conference/ 2024-06-10T20:18:00+00:00 http://staging.inmedpharma.com/news_release/inmed-pharmaceuticals-announces-favorable-behavioral-outcomes-with-inm-901-in-long-term-preclinical-alzheimers-disease-study-confirming-previous-short-term-pilot-study-data/ 2024-07-30T11:00:00+00:00 http://staging.inmedpharma.com/news_release/inmed-pharmaceuticals-demonstrates-inm-901-as-an-oral-formulation-targeting-alzheimers-disease/ 2024-08-20T10:30:00+00:00 http://staging.inmedpharma.com/news_release/inmed-pharmaceuticals-strengthens-patent-portfolio-with-issuance-of-three-u-s-patents/ 2024-08-21T10:30:00+00:00 http://staging.inmedpharma.com/news_release/inmed-receives-nasdaq-delisting-notice-and-confirms-it-has-filed-an-appeal-and-obtained-a-panel-hearing-date/ 2024-09-20T19:30:00+00:00 http://staging.inmedpharma.com/news_release/inmed-pharmaceuticals-reports-full-year-fiscal-2024-financial-results-and-provides-business-update/ 2024-09-30T11:00:00+00:00 http://staging.inmedpharma.com/news_release/inmed-appoints-dr-barry-greenberg-johns-hopkins-university-school-of-medicine-to-its-scientific-advisory-board/ 2024-10-22T11:00:00+00:00 http://staging.inmedpharma.com/news_release/inmed-to-participate-in-fierce-biotech-webinar-on-neuroinflammation-in-alzheimers-disease/ 2024-10-24T11:00:00+00:00 http://staging.inmedpharma.com/news_release/inmed-pharmaceuticals-files-additional-patent-application-for-inm-901-in-the-treatment-of-neurodegenerative-conditions-including-alzheimers-disease/ 2024-10-28T10:30:00+00:00 http://staging.inmedpharma.com/news_release/inmed-pharmaceuticals-announces-decision-by-nasdaq-hearings-panel-to-grant-exception-to-implement-share-consolidation-to-satisfy-nasdaq-listing-rules/ 2024-11-05T13:30:00+00:00 http://staging.inmedpharma.com/news_release/inmed-announces-share-consolidation-to-satisfy-nasdaq-listing-rules/ 2024-11-08T21:44:00+00:00 http://staging.inmedpharma.com/news_release/inmed-reports-first-quarter-fiscal-2025-financial-results-and-provides-business-update/ 2024-11-14T21:45:00+00:00 http://staging.inmedpharma.com/news_release/inmed-announces-publication-of-study-on-anti-inflammation-by-modulation-of-endocannabinoid-system/ 2024-11-19T12:30:00+00:00 http://staging.inmedpharma.com/news_release/inmed-enters-into-standby-equity-purchase-agreement/ 2024-12-17T21:56:00+00:00 http://staging.inmedpharma.com/news_release/inmed-announces-results-of-2024-annual-general-meeting/ 2024-12-19T01:00:00+00:00 http://staging.inmedpharma.com/news_release/inmeds-inm-901-demonstrates-statistically-significant-reduction-in-neuroinflammation-in-a-long-term-preclinical-alzheimers-disease-study/ 2025-01-21T12:30:00+00:00 http://staging.inmedpharma.com/news_release/inmed-pharmaceuticals-announces-granting-of-patent-for-novel-compounds/ 2025-01-22T12:30:00+00:00 http://staging.inmedpharma.com/news_release/inmed-announces-inm-089-intravitreal-formulation-in-the-treatment-of-dry-age-related-macular-degeneration/ 2025-02-03T12:30:00+00:00 http://staging.inmedpharma.com/news_release/inmed-reports-second-quarter-fiscal-2025-financial-results-and-provides-business-update/ 2025-02-13T00:41:11+00:00 http://staging.inmedpharma.com/news_release/inmed-reports-third-quarter-fiscal-2025-financial-results-and-provides-business-update/ 2025-05-12T21:00:00+00:00 http://staging.inmedpharma.com/news_release/inmed-appoints-cbiz-as-new-auditor-in-connection-with-cbizs-acquisition-of-marcums-attest-business-provides-update-on-special-meeting-and-makes-modifications-to-existing-sepa/ 2025-06-13T19:30:00+00:00 http://staging.inmedpharma.com/news_release/inmeds-inm-901-significantly-reduces-neuroinflammation-in-alzheimers-disease-ex-vivo-study/ 2025-06-24T10:00:00+00:00 http://staging.inmedpharma.com/news_release/inmed-pharmaceuticals-announces-5-million-private-placement-priced-at-the-market-under-nasdaq-rules/ 2025-06-25T11:00:00+00:00 http://staging.inmedpharma.com/news_release/inmed-pharmaceuticals-announces-closing-of-5-million-private-placement-priced-at-the-market-under-nasdaq-rules/ 2025-06-27T10:00:00+00:00 http://staging.inmedpharma.com/news_release/inmed-to-present-inm-901-data-at-alzheimers-association-international-conference-aaic-2025/ 2025-07-28T10:00:00+00:00 http://staging.inmedpharma.com/news_release/inmed-to-participate-in-the-h-c-wainwright-27th-annual-global-investment-conference-2/ 2025-09-05T16:33:00+00:00 http://staging.inmedpharma.com/news_release/inmed-to-present-at-the-life-sciences-virtual-investor-forum-september-18th-2025/ 2025-09-16T18:20:22+00:00 http://staging.inmedpharma.com/news_release/inmed-pharmaceuticals-reports-full-year-fiscal-2025-financial-results-and-provides-business-update/ 2025-09-23T11:30:00+00:00 http://staging.inmedpharma.com/news_release/inmed-pharmaceuticals-appoints-mr-neil-klompas-to-its-board-of-directors/ 2025-10-09T11:30:00+00:00 http://staging.inmedpharma.com/news_release/inmed-pharmaceuticals-appoints-mr-john-bathery-to-its-board-of-directors/ 2025-10-16T11:30:00+00:00 http://staging.inmedpharma.com/news_release/inmed-reports-first-quarter-fiscal-2026-financial-results-and-provides-business-update/ 2025-11-06T21:51:00+00:00 http://staging.inmedpharma.com/news_release/inmed-announces-successful-completion-of-pharmacokinetic-studies-in-large-animal-model-for-its-alzheimers-disease-candidate-inm-901/ 2025-11-18T12:30:00+00:00 http://staging.inmedpharma.com/news_release/inmed-provides-update-on-baymedica-commercial-business/ 2025-12-12T22:31:00+00:00 http://staging.inmedpharma.com/news_release/inmed-announces-results-of-2025-annual-general-and-special-meeting/ 2025-12-18T01:00:00+00:00 http://staging.inmedpharma.com/news_release/inmed-reports-second-quarter-fiscal-2026-financial-results-and-provides-business-update/ 2026-02-11T22:23:00+00:00 http://staging.inmedpharma.com/news_release/inmed-provides-update-on-baymedica-operations-and-strengthens-focus-on-pharmaceutical-development-pipeline/ 2026-03-06T22:04:00+00:00 http://staging.inmedpharma.com/news_release/inmed-provides-update-on-pharmaceutical-development-programs-advancing-lead-drug-candidates-towards-ind-and-clinical-trial/ 2026-03-09T10:30:00+00:00 http://staging.inmedpharma.com/news_release/inmed-pharmaceuticals-announces-positive-data-from-human-brain-organoid-neuroinflammation-models-supporting-the-inm-901-alzheimers-disease-program/ 2026-03-23T10:30:00+00:00 http://staging.inmedpharma.com/news_release/inmed-pharmaceuticals-receives-nasdaq-notification-regarding-minimum-bid-price-compliance-3/ 2026-03-27T20:05:00+00:00 http://staging.inmedpharma.com/news_release/inmed-pharmaceuticals-amends-preferred-investment-options/ 2026-04-27T20:30:00+00:00